Psychiatry · Lafayette, LA
NPI
1619064367
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
234 Rue Beauregard, Suite 100
Lafayette, LA, 70508
Phone (337) 593-0830
Medicare paid, 2024
$74K
1,001 services
Medicare patients, 2024
122
Average age 63
Drug cost, 2024
$175K
1,253 prescriptions
Company payments, 2025
$892
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bob Winston was code 99214 (office e&m - established), 422 times for 112 patients. In total Bob Winston billed 1,001 services in 9 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 422 | 112 | $83.73 | $35K |
| 90833 Psychotherapy - Nongroup | Office | 418 | 111 | $50.47 | $21K |
| 99215 Office E&M - Established | Office | 68 | 31 | $128.01 | $8,705 |
| 90837 Psychotherapy - Nongroup | Office | 44 | 13 | $110.64 | $4,868 |
| 90836 Psychotherapy - Nongroup | Office | 33 | 22 | $68.95 | $2,276 |
| 90792 Psychotherapy - Nongroup | Office | 13 | 13 | $128.13 | $1,666 |
By year: 2022 $43K for 572 services; 2023 $63K for 831 services; 2024 $74K for 1,001 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bob Winston prescribed most often to Medicare patients was Alprazolam, with 73 prescriptions and refills. In total Bob Winston wrote 1,253 Medicare prescriptions that cost $175K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 73 | 93 | 13 | $606 |
| Clonazepam Generic | 66 | 82 | 11 | $740 |
| Divalproex Sodium Er Divalproex Sodium | 60 | 76 | Under 11 | $5,832 |
| Trazodone Hcl Generic | 53 | 89 | 13 | $1,923 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 53 | 61 | Under 11 | $5,092 |
| Quetiapine Fumarate Generic | 51 | 59 | Under 11 | $656 |
| Benztropine Mesylate Generic | 44 | 51 | Under 11 | $465 |
| Oxcarbazepine Generic | 40 | 48 | Under 11 | $3,220 |
| Mirtazapine Generic | 39 | 52 | Under 11 | $287 |
| Olanzapine Generic | 37 | 37 | Under 11 | $897 |
| Fluoxetine Hcl Generic | 37 | 41 | Under 11 | $1,012 |
| Diazepam Generic | 35 | 35 | Under 11 | $342 |
| Ziprasidone Hcl Generic | 34 | 55 | Under 11 | $659 |
| Fluvoxamine Maleate Er Fluvoxamine Maleate | 33 | 51 | Under 11 | $18K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 32 | 50 | Under 11 | $444 |
Brand drugs: - claims; generic drugs: 1,185 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bob Winston $892 ($892 in general payments such as food, travel and fees) from 13 companies. The largest payer was Vanda Pharmaceuticals Inc. with $193.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 11 | $193 |
| Alkermes, Inc. ALKS | 3 | $133 |
| Axsome Therapeutics, Inc. AXSM | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $89.35 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $74.69 |
| Lundbeck LLC | 3 | $65.81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $53.24 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $43.17 |
| Abbvie Inc. ABBV | 2 | $41.13 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $27.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.